financetom
Business
financetom
/
Business
/
Northern Oil & Gas Approves $150 Million Share Buyback Authorization, Plans 5% Increase to Quarterly Dividend
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Northern Oil & Gas Approves $150 Million Share Buyback Authorization, Plans 5% Increase to Quarterly Dividend
Jul 29, 2024 5:29 AM

08:14 AM EDT, 07/29/2024 (MT Newswires) -- Northern Oil & Gas (NOG) said Monday that its board has approved a new $150 million share buyback authorization, replacing its previous authorization that had been significantly depleted.

The company said its management expects to submit a request to the board for a 5%, or $0.02, mid-year raise in the quarterly common dividend to $0.42 per share for Q3.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
AppFolio Q1 Non-GAAP EPS, Revenue Rise; Shares Gain After Hours
AppFolio Q1 Non-GAAP EPS, Revenue Rise; Shares Gain After Hours
Apr 23, 2026
04:24 PM EDT, 04/23/2026 (MT Newswires) -- AppFolio ( APPF ) reported Q1 non-GAAP diluted earnings late Thursday of $1.61 per share, up from $1.21 a year earlier. Analysts polled by FactSet expected $1.47. Revenue in the three months ended March 31 rose to $262.2 million from $217.7 million a year earlier. Analysts polled by FactSet expected $258.1 million. The...
Carlisle Q1 Adjusted Earnings Rise, Revenue Declines
Carlisle Q1 Adjusted Earnings Rise, Revenue Declines
Apr 23, 2026
04:26 PM EDT, 04/23/2026 (MT Newswires) -- Carlisle (CSL) reported Q1 adjusted earnings late Thursday of $3.63 per diluted share, up from $3.61 a year earlier. Analysts polled by FactSet expected $3.33. Revenue for the quarter ended March 31 was $1.05 billion, down from $1.10 billion a year earlier. Analysts surveyed by FactSet expected $1.06 billion. ...
US FDA rejects AbbVie's wrinkle treatment due to manufacturing concerns
US FDA rejects AbbVie's wrinkle treatment due to manufacturing concerns
Apr 23, 2026
April 23 (Reuters) - AbbVie ( ABBV ) said on Thursday the U.S. Food and Drug Administration has declined to approve its experimental wrinkle treatment, citing issues in manufacturing. The company said the agency did not raise concerns about the treatment's safety or efficacy, and did not ask for new patient studies. TrenibotE is a fast-acting botulinum toxin aimed at...
Kinsale Capital Q1 Adjusted Earnings, Revenue Rise
Kinsale Capital Q1 Adjusted Earnings, Revenue Rise
Apr 23, 2026
04:25 PM EDT, 04/23/2026 (MT Newswires) -- Kinsale Capital Group ( KNSL ) reported Q1 adjusted earnings late Thursday of $5.11 per diluted share, up from $3.71 a year earlier. Analysts polled by FactSet expected $4.66. Revenue for the three months ended March 31 was $466.7 million, up from $423.4 million a year earlier. Analysts surveyed by FactSet expected $470.5...
Copyright 2023-2026 - www.financetom.com All Rights Reserved